Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by 99942Apophison Jan 21, 2022 12:18pm
926 Views
Post# 34343015

RE:New Photosensitizers from Mushrooms

RE:New Photosensitizers from MushroomsGood find Eoganacht 

The genus Cortinarius is one of the most diverse genera of mushrooms, with around 2000 species described worldwide (Garnica et al., 2005). Already, more than 100 species are known from Australia (May et al., 2009) and recent taxonomic research on the genus has continued to distinguish novel species (Gasparini and Soop, 2008;Jones and May, 2008). Dermocybe has been variously treated as a distinct genus or as a subgenus of Cortinarius (Hiland, 1983). 


Also a note to amateur seekers that this family has an abundance of poisonous shrooms and should only be collected by a knowledgeable mushroom hunter. There are 8 points of identification per mushroom. 
<< Previous
Bullboard Posts
Next >>